Skip to main content
2025 PharmSci 360 Main banner
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.

Francesca Buttini, MPharm, PhD (she/her/hers)

Associate Professor
University of Parma
Parma, Emilia-Romagna, Italy

Francesca Buttini is holding an Associate Professor position at the Food and Drug Department, University of Parma (IT) and where now she is leading the unit dedicated to design of pharmaceutical products for inhalation. Since 2014, she has been appointed as Visiting Lecturer at the Institute of Pharmaceutical Science of King’s College London (UK).
Combining her background in pharmaceutical technology, regulatory aspects, and device design, she is executing research programs aimed to deliver medicinal products that take into consideration the patient, industrial and regulatory requirements. Her research activity is focused on proteins, peptides and probiotics in dry powder inhalers, new treatments for unmet medical needs and on the transition of pressurized metered dose inhalers towards new sustainable propellants.
Up to date, she has published more than 100 original papers, 12 patents and as a result of her research achievement she obtained in 2017 the DDL Emerging Scientist Awards from the UK Aerosol Society. Francesca is a founder of PlumeStars, an innovative SME, dedicated to development of orphan drug products to treat lung and systemic disease by inhalation therapy and is a member of the scientific advisory board of Alveolus Bio, a company aiming to targeted probiotics directly to the lungs.

Disclosure information not submitted.

Presentation(s):